Structural characterization of mycobacterial phosphatidylinositol mannoside binding to mouse CD1d

Journal of Immunology

Volumn 177, Issue 7, 2006, Pages 4577-4583

  Zajonc, Dirk M ^a,c   Ainge, Gary D ^b   Painter, Gavin F ^b   Severn, Wayne B ^b   Wilson, Ian A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b CALLAGHAN INNOVATION   (New Zealand)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; DIACYLGLYCEROL; INOSITOL; LIPOARABINOMANNAN; LIPOMANNAN; MANNOSIDE; PHOSPHATE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL MANNOSIDE; SPHINGOLIPID; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANTIBODY COMBINING SITE; ANTIGEN BINDING; ANTIGEN PRESENTATION; ARTICLE; CRYSTAL STRUCTURE; HYDROGEN BOND; HYDROPHOBICITY; INSECT CELL; LEPIDOPTERA; LIPID COMPOSITION; MYCOBACTERIUM; NATURAL KILLER T CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; STEREOCHEMISTRY;

EID: 33749156209     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.7.4577     Document Type: Article

References (56)

1. Brennan, P. J., and H. Nikaido. 1995. The envelope of mycobacteria. Annu. Rev. Biochem. 64: 29-63.
2. Brennan, P. J. 2003. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis 83: 91-97.
3. Chan, J., X. D. Fan, S. W. Hunter, P. J. Brennan, and B. R. Bloom. 1991. Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages. Infect. Immun. 59: 1755-1761.
4. Sibley, L. D., S. W. Hunter, P. J. Brennan, and J. L. Krahenbuhl. 1988. Mycobacterial lipoarabinomannan inhibits γ interferon-mediated activation of macrophages. Infect. Immun. 56: 1232-1236.
5. Barnes, P. F., D. Chatterjee, J. S. Abrams, S. Lu, E. Wang, M. Yamamura, P. J. Brennan, and R. L. Modlin. 1992. Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan: relationship to chemical structure. J. Immunol. 149: 541-547.
6. Prigozy, T. I., P. A. Sieling, D. Clemens, P. L. Stewart, S. M. Behar, S. A. Porcelli, M. B. Brenner, R. L. Modlin, and M. Kronenberg. 1997. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity 6: 187-197.
7. Winau, F., V. Schwierzeck, R. Hurwitz, N. Remmel, P. A. Sieling, R. L. Modlin, S. A. Porcelli, V. Brinkmann, M. Sugita, K. Sandhoff, et al. 2004. Saposin C is required for lipid presentation by human CD1b. Nat. Immunol. 5: 169-174.
8. Moody, D. B., D. M. Zajonc, and I. A. Wilson. 2005. Anatomy of CD1-lipid antigen complexes. Nat. Rev. Immunol. 5: 387-399.
9. Calabi, F., J. M. Jarvis, L. Martin, and C. Milstein. 1989. Two classes of CD1 genes. Eur. J. Immunol. 19: 285-292.
10. Brigl, M., and M. B. Brenner. 2004. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22: 817-890.
11. Kronenberg, M. 2005. Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23: 877-900.
12. Kawano, T., J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, E. Kondo, et al. 1997. CD1d-restricted and TCR-mediated activation of Vαl4 NKT cells by glycosylceramides. Science 278: 1626-1629.
13. Mattner, J., K. L. Debord, N. Ismail, R. D. Goff, C. Cantu III, D. Zhou, P. Saint-Mezard, V. Wang, Y. Gao, N. Yin, et al. 2005. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525-529.
14. Kinjo, Y., D. Wu, G. Kim, G. W, Xing, M, A. Poles, D. D. Ho, M. Tsuji, K. Kawahara, C. H. Wong, and M. Kronenberg. 2005. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434: 520-525.
15. Fischer, K., E. Scotet, M. Niemeyer, H. Koebernick, J. Zerrahn, S. Maillet, R. Hurwitz, M. Kursar, M. Bonneville, S. H. Kaufmann, and U. E. Schaible. 2004. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc. Natl. Acad. Sci. USA 101: 10685-10690.
16. Zhou, D., J. Mattner, C. Cantu III, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv, K. Hudspeth, Y. P. Wu, T. Yamashita, et al. Lysosomal glycosphingolipid recognition by NKT cells. Science 306: 1786-1789.
17. Wu, D., D. M. Zajonc, M. Fujio, B. A. Sullivan, Y. Kinjo, M. Kronenberg, I. A. Wilson, and C. H. Wong. 2006. Design of NKT-cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d. Proc. Natl. Acad. Sci. USA 103: 3972-3977.
18. Zajonc, D. M., C. Cantu, J. Mattner, D. Zhou, P. B. Savage, A. Bendelac, I. A. Wilson, and L. Teyton. 2005. Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor. Nat. Immunol. 8: 810-818.
19. Koch, M., V. S. Stronge, D. Shepherd, S. D. Gadola, B. Mathew, G. Ritter, A. R. Fersht, G. S. Besra, R. R. Schmidt, E. Y. Jones, and V. Cerundolo. 2005. The crystal structure of human CD1d with and without α-galactosylceramide. Nat. Immunol. 8: 819-826.
20. Zajonc, D. M., M. A. Elsliger, L. Teyton, and I. A. Wilson. 2003. Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 Å. Nat. Immunol. 4: 808-815.
21. Zajonc, D. M., M. D. Crispin, T. A. Bowden, D. C. Young, T. Y. Cheng, J. Hu, C. E. Costello, P. M. Rudd, R. A. Dwek, M. J. Miller, et al. 2005. Molecular mechanism of lipopeptide presentation by CD1a. Immunity 22: 209-219.
22. Gadola, S. D., N. R. Zaccai, K. Harlos, D. Shepherd, J. C. Castro-Palomino, G. Ritter, R. R. Schmidt, E. Y. Jones, and V. Cerundolo. 2002. Structure of human CD1b with bound ligands at 2.3 Å, a maze for alkyl chains. Nat. Immunol. 3: 721-726,
23. Batuwangala, T., D. Shepherd, S. D. Gadola, K. J. Gibson, N. R. Zaccai, A. R. Fersht, G. S. Besra, V. Cerundolo, and E. Y. Jones. 2004. The crystal structure of human CD1b with a bound bacterial glycolipid. J. Immunol. 172: 2382-2388.
24. Giabbai, B., S. Sidobre, M. D. Crispin, Y. Sanchez-Ruiz, A. Bachi, M. Kronenberg, I. A. Wilson, and M. Degano. 2005. Crystal structure of mouse CD1d bound to the self ligand phosphatidylcholine: a molecular basis for NKT cell activation. J. Immunol. 175: 977-984.
25. Ernst, W. A., J. Maher, S. Cho, K. R. Niazi, D. Chatterjee, D. B. Moody, G. S. Besra, Y. Watanabe, P. E. Jensen, S. A. Porcelli, et al. 1998. Molecular interaction of CD1b with lipoglycan antigens. Immunity 8: 331-340.
26. Sieling, P. A., D. Chatterjee, S. A. Porcelii, T. I. Prigozy, R. J. Mazzaccaro, T. Soriano, B. R. Bloom, M. B. Brenner, M. Kronenberg, P. J. Brennan, et al. 1995. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 269: 227-230.
27. Jayaprakash, K. N., J. Lu, and B. Fraser-Reid. 2004. Synthesis of a key Mycobacterium tuberculosis biosynthetic phcsphoinositide intermediate. Bioorg. Med. Chem. Lett. 14: 3815-3819.
28. Ainge, G. D., J. Hudson, D. S. Larsen, G. F. Painter, G. Singh Gill, and J. L. Harper. 2006. Phosphatidylinositol mannosides: synthesis and suppression of allergic airway disease Bioorg. Med. Chem. 15: 5632-5642.
29. Zajonc, D. M., I. Maricic, D. Wu, R. Halder, K. Roy, C. H. Wong, V. Kumar, and I. A. Wilson. 2005. Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity. J. Exp. Med. 202: 1517-1526.
30. Otwinowski, Z., and W. Minor. 1997. HKL: Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276: 307-326.
31. CCP4. 1994. Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50: 760-763.
32. Vagin, A. A., and A. Teplyakov. 1997. MOLREP: an automated program for molecular replacement. J. App. Cryst. 30: 1022-1025.
33. Brünger, A. T. 1992. Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature. 355: 472-475.
34. Jones, T. A., J. Y. Zou, S. Cowan, and M. Kjeldgaard. 1991. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47: 110-119.
35. Murshudov, G. N., A. A. Vagin, and E. S. Dodson. 1997. Refinement of macromolecular structures by the maximum likelihood method. Acta Crystallogr. D 53: 240-255.
36. Schuettelkopf, A. W., and D. M. van Aalten. 2004. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr. D 60: 1355-1363.
37. Winn, M. D., M. N. Isupov, and G. N. Murshudov. 2001. Use of TLS parameters to model anisotropic displacements in macromolecular refinement. Acta Crystallogr. D 57: 122-133.
38. Lovell, S. C., I. W. Davis, W. B. Arendall III, P. I. de Bakker, J. M. Word, M. G. Prisant, J. S. Richardson, and D. C. Richardson. 2003. Structure validation by Cα geometry: φ,ψ, and Cβ deviation. Proteins 50: 437-450.
39. Dolinsky, T. J., J. E. Nielsen, J. A. McCammon, and N. A. Baker. 2004. PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res. 32:W665-W667.
40. Baker, N. A., D. Sept, S. Joseph, M. J. Holst, and J. A. McCammon. 2001. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc. Natl. Acad. Sci. USA 98: 10037-10041.
41. Howlin, B., D. S. Butler, D. S. Moss, G. W. Harris, and H. P. C. Driessen. 1993. TLSANL: TLS parameter analysis program for segmented anisotropic refinement of macromolecular structures. J. Appl. Cryst. 26: 622-624.
42. Zeng, Z., A. R. Castano, B. W. Segelke, E. A. Stura, P. A. Peterson, and I. A. Wilson. 1997. Crystal structure of mouse CD1: an MHC-like fold with a large hydrophobic binding groove. Science 277: 339-345.
43. Wakil, S. J., J. K. Stoops, and V. C. Joshi. 1983. Fatty acid synthesis and its regulation. Annu. Rev. Biochem. 52: 537-579.
44. World Health Organization. 1999. The World Health Report 1999: Making a Difference, Geneva.
45. Beatty, W. L., E. R. Rhoades, H. J. Ullrich, D. Chatterjee, J. E. Heuser, and D. G. Russell. 2000. Trafficking and release of mycobacterial lipids from infected macrophages. Traffic 1: 235-247.
46. Schaible, U. E., K. Hagens, K. Fischer, H. L. Collins, and S. H. Kaufmann. 2000. Intersection of group I CD1 molecules and mycobacteria in different intracellular compartments of dendritic cells. J. Immunol. 164: 4843-4852.
47. De Libero, G., and L. Mori. 2005. Recognition of lipid antigens by T cells. Nat. Rev. Immunol. 5: 485-496.
48. Gumperz, J. E. 2006. The ins and outs of CD1 molecules: bringing lipids under immunological surveillance. Traffic 1: 2-13.
49. Gilleron, M., V. F. Quesniaux, and G. Puzo. 2003. Acylation state of the phosphatidylinositol hexamannosides from Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv and its implication in Toll-like receptor response. J. Biol Chem. 278: 29880-29889.
50. Rudolph, M. G., R. L. Stanfield, and I. A. Wilson. 2006. How TCRs bind MHCs, peptides, and coreceptors. Annu. Rev. Immunol. 24: 419-466.
51. Garcia, K. C., L. Teyton, and I. A. Wilson. 1999. Structural basis of T cell recognition. Annu. Rev. Immunol. 17: 369-397.
52. Godfrey, D. I., J. McCluskey, and J. Rossjohn. 2005. CD1d antigen presentation: treats for NKT cells. Nat. Immunol. 6: 754-756.
53. Gadola, S. D., M. Koch, J. Marles-Wright, N. M. Lissin, D. Shepherd, G. Matulis, K. Harlos, P. M. Villiger, D. I. Stuart, B. K. Jakobsen, et al. 2006. Structure and binding kinetics of three different human CD1d-α- galactosylceramide-specific T cell receptors. J. Exp. Med. 203: 699-710.
54. Kjer-Nielsen, L., N. A. Borg, D. G. Pellicci, T. Beddoe, L. Kostenko, C. S. Clements, N. A. Williamson, M. J. Smyth, G. S. Besra, H. H. Reid, et al. 2006. A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition. J. Exp. Med. 203: 661-673.
55. Gilleron, M., C. Ronet, M. Mempel, B. Monsarrat, G. Gachelin, and G. Puzo. 2001. Acylation state of the phosphatidylinositol mannosides from Mycobacterium bovis BCG and ability to induce granuloma and recruit natural killer T cells. J. Biol. Chem. 276: 34896-34904.
56. Gilleron, M., J. Nigou, B. Cahuzac, and G. Puzo. 1999. Structural study of the lipomannans from Mycobacterium bovis BCG: characterisation of multiacylated forms of the phosphatidyl-myo-inositol anchor. J. Mol. Biol. 285: 2147-2160.